Equine West Nile Encephalitis, United States
Year: 2001
Type: article
Abstract: West Nile VirusIn October 1999, West Nile (WN) virus was first confirmed as the cause of illness in a horse in the Western Hemisphere.A Suffolk County, New York, horse was 1 of 25 on Long Island that were eventually diagnosed with WN encephalitis in 1999.Nine (36%) of the infected horses died or were euthanized.A limited number of veterinary diagnostic tests were available during the 1999 outbreak.Few laboratories were prepared to conduct diagnostic tests, in part because WN virus is categorized as a biosafety level 3 agent (1).The United States Department of Agriculture, Animal and Plant Health Inspection Service (APHIS), Veterinary Services, National Veterinary Services Laboratories (NVSL), Ames, Iowa, which is an international veterinary reference laboratory for diagnosis of eastern, western, and Venezuelan equine encephalomyelitis (EEE, WEE, VEE), provided diagnostic tests for WN virus.Plaque-reduction neutralization tests (PRNT) of equine serum (2) and virus isolation from equine brain or spinal cord tissues were the primary WN virus laboratory methods available in 1999.Most submissions to the NVSL in 1999 were coordinated by APHIS Veterinary Services as exotic disease investigations.Evidence gathered during the winter of 1999-2000 indicated that WN virus was still present in birds and mosquitoes in the New York City area.In early February 2000, WN virus was isolated from a Red-tailed Hawk that died in Westchester County, New York (3).Adult Culex mosquitoes collected from structures in New York City during January and February 2000 were found to be infected with WN virus (4,5).Given these findings, epizootic levels of WN virus activity were thought likely to recur in the summer of 2000.The laboratory methods used to detect WN virus infection and exposure in horses served well in the initial outbreak in 1999.However, with evidence that the virus had become established in the northeastern United States, the number and range of horses exposed to WN virus were expected to increase.To facilitate detection of new equine WN virus infections, an immunoglobulin (Ig) M-capture enzyme-linked immunosorbent assay (MAC-ELISA) was developed.The assay, modeled after an EEE MAC-ELISA, used an inactivated WN virus antigen from neonatal mouse brain (6).Serum samples collected during the 1999 WN virus outbreak were used to validate the assay.Results of experimental challenge of a small number of horses showed that IgM isotype anti-WN virus antibodies became detectable 8-10 days after infection and persisted <2 months in the challenge model (Ostlund et al., unpub.data).Based on sequential samples collected from a few horses in the New York WN virus outbreak in 1999, the decay of IgM antibodies in naturally infected horses appeared to be similar (7).Given the possibility of equine cases of WN encephalitis recurring, a case definition was developed by APHIS Veterinary Services in the spring of 2000.Clinical signs used in the definition were based primarily on the 1999 experience in the United States because descriptions of clinical equine cases of WN encephalitis in other parts of the world were limited (8-12).To assure comparability and consistency of results, all diagnostic testing referred to in the case definition was required to be performed or confirmed in the same laboratory.Because specimens might originate from multiple states, the laboratory designated to test all specimens was the NVSL.We evaluated diagnostic test results in combination with clinical observations to accurately identify cases of WN encephalitis in horses. Methods Characterization of Clinical IllnessDates of onset and signs of clinical illness were obtained from field investigators' interviews with animal owners or care givers or from history forms accompanying specimens submitted to primary or reference diagnostic laboratories.Date of onset of illness was considered to be the first time at which any sign of illness was observed that led to a sign specified in the case definition. Laboratory TestsSpecimens included serum, whole blood, cerebrospinal fluid (CSF), brain, and spinal cord tissue.Not all submissions included each sample type.
Source: Emerging infectious diseases
Authors: Eileen N. Ostlund, Randall L. Crom, Douglas D. Pedersen, Donna J. Johnson, W. Oliver Williams, Beverly J. Schmitt
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2118532620
